Occudo Quantitative Strategies LP Ocuphire Pharma, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.01 - $3.85 $59,065 - $75,548	19,623 New	19,623 $73,000
Q2 2022 Aug 15, 2022	SELL	$1.8 - $3.25 $33,480 - $60,450	-18,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.75 - $4.39 $412 - $658	150 Added 0.81%	18,600 $60,000
Q4 2021 Feb 14, 2022	SELL	$3.4 - $5.19 $11,114 - $16,966	-3,269 Reduced 15.05%	18,450 $69,000
Q3 2021 Nov 15, 2021	SELL	$3.84 - $5.38 $6,627 - $9,285	-1,726 Reduced 7.36%	21,719 $112,000
Q2 2021 Aug 16, 2021	BUY	$4.24 - $6.57 $99,406 - $154,033	23,445 New	23,445 $124,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.